NovoCure Ltd. (NVCR)
13.04
-1.19
(-8.36%)
USD |
NASDAQ |
Mar 06, 16:00
13.04
0.00 (0.00%)
After-Hours: 20:00
NovoCure Cash from Investing (TTM) : 437.28M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| LivaNova Plc | -72.91M |
| AtriCure, Inc. | -14.55M |
| Abbott Laboratories | -2.422B |
| Accuray, Inc. | -15.25M |
| Plus Therapeutics, Inc. | 0.287M |